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One Sentence Summary: Proteomic analysis of rat cortical neurons revealed that over 600 
nuclear proteins are modified by S-nitrosylation, including proteins involved in the regulation of gene 
expression such as CREB and RBBP7. 
 
Abstract: The ability of neurons to modulate gene expression in response to extrinsic signals is 
necessary for proper brain function. S-nitrosylation is the covalent attachment of a nitric oxide (NO) 
moiety to cysteine thiols and is critical for transducing extracellular stimuli into specific patterns of 
gene expression. In the cerebral cortex, S-nitrosylation of histone deacetylase 2 (HDAC2) is required 
for gene transcription during neuronal development, however only few nuclear targets of S-
nitrosylation have been identified to date. Here, we used S-nitrosothiol Resin Assisted Capture 
(SNORAC) coupled with mass spectrometry analysis to identify 614 S-nitrosylated nuclear proteins. 
Of these, 131 proteins had never been shown to be S-nitrosylated in any system, and 612 are new 
targets of S-nitrosylation in neurons. The site(s) of S-nitrosylation were identified for 59% of the 
targets, and motifs containing single lysines found at 33% of these sites. In addition, lysine motifs 
were found to be necessary for promoting S-nitrosylation of HDAC2 and Methyl-CpG Binding 
Protein 3 (MBD3). Moreover, S-nitrosylation of the histone binding protein RBBP7 was found to be 
necessary for dendritogenesis. Overall, our study provides the first extensive characterization of S-
nitrosylated nuclear proteins in neurons and identifies putative S-nitrosylation motifs that may be 
shared with other targets of nitric oxide signaling. 
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Introduction 
S-nitrosylation is a nitric oxide (NO)-dependent posttranslational modification that affects protein 
functions by regulating enzymatic activity, sub-cellular localisation or protein-protein interactions (1-
3). Though over 3000 S-nitrosylated proteins have been identified to date, these include few nuclear 
proteins (4-6). In the rodent brain, expression of the enzyme responsible for neuronal nitric oxide 
production, the neuronal Nitric Oxide Synthase (nNOS) is developmentally regulated, and peaks 
during the mid-to-late embryonic stages during which the layered structure of the cortex is established 
(7). We previously showed that S-nitrosylation of histone deacetylase 2 (HDAC2) during this period 
results in dissociation of HDAC2 from chromatin, promoting histone acetylation and expression of 
CREB-dependent genes that are critical for neuronal migration (4, 8). S-nitrosylation of HDAC2 is 
also important in the adult brain; in the hippocampus for example, S-nitrosylation of HDAC2 is 
required for the updating of fear memories (9). Other examples of nuclear S-nitrosylation include 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which is S-nitrosylated in the cytoplasm and 
translocates in the nucleus where it trans-nitrosylates several proteins, including HDAC2 (5, 10). 
Moreover, the transcription factor myocyte enhancer factor 2C (MEF2C) is S-nitrosylated in neurons 
in response to excitotoxic insults, resulting in reduced transcriptional activity and increased cell death 
(6, 11).  
Previous proteomic screens provided few nuclear targets of S-nitrosylation in mammalian cells 
(12-14). To identify nuclear proteins that are potential targets of S-nitrosylation in neurons, we 
performed S-nitrosothiol Resin Assisted Capture (SNORAC) (15) on nuclear extracts of rat cortical 
neurons treated with CysNO.  Mass spectrometry identified 614 nuclear targets of S-nitrosylation, as 
well as the site(s) of S-nitrosylation for most hits. In addition, Motif-X analysis revealed four lysine-
containing motifs that promote S-nitrosylation of nearby cysteines. We found that proteins involved in 
metabolism, development and regulation of gene expression were modified by S-nitrosylation. Most 
subunits of the chromatin remodelling complex Nucleosome Remodelling and Deacetylase complex 
(NuRD) were found to be S-nitrosylated.  Further analysis of the histone binding protein 
retinoblastoma binding protein 7 (RBBP7) revealed that S-nitrosylation at cysteine 166 was required 
for activity-induced dendritogenesis and regulated its interaction with the Chromodomain Helicase 
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DNA 4 (CHD4) subunit.  The transcription factor CREB were also found to be S-nitrosylated in 
response to CysNO donors and following neuronal depolarisation. Our study provides the first SNO-
proteome of neuronal proteins that may be used to study the function of nuclear S-nitrosylation in 
neurons in vitro or during cortical development in vivo.  
 
Results 
Identification of S-nitrosylated nuclear proteins in cortical neurons 
To obtain a comprehensive analysis of nuclear S-nitrosylation in neurons, nuclear extracts from 
E17 rat cortical neurons were treated with the NO donor CysNO, and S-nitrosylated proteins were 
isolated using SNORAC (Fig.1A) (15). Eluted proteins were subjected to SDS-PAGE and silver 
staining to assess total SNO-proteins (Fig.1B). As a control, we used HDAC2 (Fig.1B and Fig.S1A 
and Fig.S1B), a known nuclear target of S-nitrosylation (4, 5, 8, 9). Corresponding samples were 
analysed using quantitative mass spectrometry (LC MS/MS, see Methods) to obtain the identification 
of SNO-proteins and the respective sites of S-nitrosylation. 71.75% of the identified proteins were 
detected as increased in CysNO-treated samples (Fig.1C), indicating that the SNORAC technique 
allows a significant enrichment of S-nitrosylated proteins. The remaining proteins were either 
unchanged across conditions (24.37%) or enriched in controls (3.88%), and were excluded from 
further analysis. 5 experiments were carried out in total; 2 using CysNO at a 1mM concentration and 
3 using 200M CysNO (Table S1 and Fig.S1C-E). Despite variability in the number of SNO-
proteins identified in each experiment (Table S1 and Fig.S1C), 88.2% of the proteins identified using 
1mM CysNO were also S-nitrosylated using 200M CysNO (Fig.S1D), indicating that at both 
concentrations CysNO induced robust S-nitrosylation of a similar set of proteins. Proteins were 
designated as S-nitrosylated if they were enriched ≥2 fold in CysNO versus control samples in at least 
3 independent experiments (See Methods for a description of the criteria used). 614 S-nitrosylated 
proteins (SNO-Ps) met these criteria (Table S2), of which 131 (38.1%) were novel targets of S-
nitrosylation across all systems assayed to date, whereas 612 (99.7%) had not been previously 
identified as targets of S-nitrosylation in neurons. A higher number of hits was found when the S-
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nitrosylated protein datasets were analysed using stringency conditions of ≥1.3 fold in CysNO versus 
control samples in at least 3 independent experiments (Table S3) or ≥1.5 fold in CysNO versus 
control samples in at least 2 independent experiments (Table S4). We also probed experiments 1-4 for 
proteins that are basally S-nitrosylated, by searching for proteins detected as unchanged in CysNO vs 
Cys, but increased in CysNO versus CysNO w/o ascorbate (Table S5). We observed that these 
proteins did not overlap with proteins detected as unchanged across all conditions (Table S6). 
 
Gene ontology (GO) analysis of nuclear SNO-Ps 
To determine whether certain types of proteins were enriched in our dataset, GO 
overrepresentation analysis (PANTHER GO analysis, see Methods) was carried out on the SNO-P 
dataset. First, untreated nuclear extracts from E17 cortical neurons were analysed by MS to generate a 
reference nuclear proteome of 3078 proteins (Table S7). Using this dataset as background, we found 
that 4 pathways were significantly enriched in the SNO-P dataset: Huntington disease (3.48 fold 
enriched), dopamine receptor mediated signalling (4.09 fold enriched), Wnt signalling (2.61 fold 
enriched) and nicotine pharmacodynamics pathway (5.41 fold enriched) (Fig.S2A). Annotations for 
molecular functions (Fig.S2B) indicated that chromatin-binding proteins were significantly enriched 
in the SNO-P dataset (1.99 fold). Whilst several terms associated with regulation of protein binding 
were overrepresented in SNO-Ps (Fig.S2B), hydrolase activity was the only term linked to regulation 
of protein activity (1.85 fold). Overrepresentation analysis for biological processes revealed that 4/29 
terms assigned (13.8%) related to metabolic processes (Fig.S2C), whereas 4/29 (13.8%) concerned 
development. Remarkably, 2 terms were associated with regulation of gene expression (gene 
expression, 2.50 fold, and positive regulation of gene expression, 1.47 fold; Fig.S2C). Nucleic acid 
binding proteins were amongst the enriched terms in regard to protein class (3.11 fold, Fig.S2D). A 
summary of standard GO classifications, that does not take into account the relative occurrence of 
each term compared to the background nuclear protein dataset is displayed in Fig.S3A. Overall, our 
data indicate that S-nitrosylation of nuclear proteins may represent a mechanism that regulates 
metabolic, developmental and genetic processes. 
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In addition to nuclear extracts, corresponding extracts from the cytoplasmic compartment of E17 
cortical neurons were exposed to CysNO and used to identify cytoplasmic SNO-Ps (see Methods, 
Fig.S1B and Table S8). As expected, our nuclear and cytoplasmic proteins datasets are largely 
distinct with 84.4% of detections unique to either dataset. GO analysis also revealed striking 
differences in annotations (Fig.S3B-D). 
 
S-nitrosylation of nuclear factors in cortical neurons 
We next sought to study S-nitrosylation of nuclear proteins that are involved in the regulation of 
gene expression and are especially relevant for neuronal functions. We considered SNO-Ps annotated 
with the GO terms transcription, DNA-dependent (GO:0006351) (Table S9) and chromatin 
organization (GO:0006325) (Table S10). The transcription factor cAMP-responsive element binding 
protein 1 (CREB1) (Table S9, hit number 6) regulates the transcription of genes essential for 
differentiation and survival of cortical neurons (16, 17). We previously demonstrated that NO 
regulates CREB-dependent gene expression (17) and that S-nitrosylation of histone deacetylase 2 
(HDAC2) is necessary for CREB-activated transcription (4, 8). However, whether CREB is S-
nitrosylated in neurons remained unknown. To investigate S-nitrosylation of specific nuclear proteins, 
we used the biotin switch assay (18). In this assay, S-nitrosylated cysteines are labelled with biotin 
and subsequently isolated using streptavidin capture. Biotin switch performed on cortical neurons 
exposed to CysNO confirmed that CREB is S-nitrosylated (Fig.2A). Strikingly, depolarisation of 
cortical neurons with KCl also induced S-nitrosylation of CREB (Fig.2B).  
The retinoblastoma binding protein 7 (RBBP7) (Table S10, hit number 6) is a histone-binding 
protein associated with several chromatin-modifying complexes that regulate gene expression in 
neurons (19-21), including the NuRD complex. NuRD regulates cortical development in mouse (19, 
21), however whether the subunits are post-translationally modified in response to extrinsic signals is 
unknown. We found that in cortical neurons, RBBP7 is S-nitrosylated in response to CysNO-
treatment and depolarization (Fig.2C and Fig.2D) as well as following exposure to GSNO (Fig.S4). 
In addition to RBBP7, CHD3, CHD4 and CHD5, the ATPase subunits of the NuRD complex, were all 
detected as S-nitrosylated in the SNO-P dataset (Table S2, hit number 372, 373 and 87) and in 
 6 
CysNO-treated HEK293T cell lysates (Fig.S5). Taken together, these findings demonstrate that our 
SNORAC screen identifies novel nuclear targets of S-nitrosylation, and suggest that S-nitrosylation 
may regulate chromatin remodeling complexes. 
 
Identification of S-nitrosylated cysteines and putative S-nitrosylation motifs 
To identify the cysteines modified by nitrosylation (SNO-sites), a second elution step was 
performed during SNORAC, which allowed the release of previously nitrosylated fragments from the 
resin. The fragments were then identified by LC MS/MS (Fig.1A and Methods). SNO-peptide 
analysis of experiment 5 detected 4368 cysteine-containing peptides in the CysNO sample (Table 
S11) and 1103 in the Cys control (Table S12). To identify SNO-sites, we analysed peptides detected 
in the CysNO dataset that belonged to proteins present in the SNO-protein dataset (Table S2). Using 
this approach, we assigned 942 unique SNO-sites across 360 proteins (Table S13). SNO-sites for 
proteins assigned using less stringent conditions are also provided (Table S14 and Table S15). 
Next, we searched for amino acid motifs that render certain cysteines more prone to nitrosylation, 
such as sequences containing acidic or basic residues either immediately flanking (22) or distal to the 
SNO-site (23). Motif-X (motif-x.med.harvard.edu, see Methods) revealed that lysine containing 
motifs were present in 277 of the 849 mappable SNO-sites (32.6%, Fig.3A). Whether specific lysine 
motifs are preferentially found in certain protein types in unknown, however GO analysis of proteins 
containing each lysine motif revealed differences in regards to annotations for biological process 
(Fig.3B). We investigated the functional relevance of the lysine(s) by assessing their effect on S-
nitrosylation of the NuRD complex protein MBD3 (Table S13, hit number 271). SNO-site analysis 
was performed on MBD3 by generating DNA vectors expressing either the wild type protein or 
mutant forms bearing a mutation of the nitrosylated cysteines to serine (C215S and C266S), or 
mutation of lysine 264 to alanine (Lysine motif 1, K264A). CysNO-dependent S-nitrosylation of 
MBD3C215S/C266S was significantly reduced in HEK293T cells (Fig.3C), indicating that the cysteines 
identified by the SNORAC were indeed S-nitrosylated. Strikingly, K264 mutation either alongside 
C215S or alone also led to a drastic decrease of MBD3 S-nitrosylation. We previously demonstrated 
that HDAC2 is S-nitrosylated at C262 and C274 in neurons (4). Here, CysNO-induced S-nitrosylation 
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of HDAC2 was assessed upon mutation of HDAC2 lysine 280 to alanine (Lysine motif 2; K280A; 
Table S13, hit number 237) alone or in association with C262A (Fig.3D). Our findings indicate that a 
single lysine in the immediate area surrounding a cysteine is sufficient to promote S-nitrosylation at 
that site.  
 
Sites of S-nitrosylation on CREB and RBBP7 
To explore the physiological implications of S-nitrosylation of selected nuclear proteins, the site(s) 
of S-nitrosylation of CREB and RBBP7 were further investigated. SNO-peptide analysis failed to 
identify the cysteine(s) modified on CREB, possibly due to the small size of the predicted tryptic 
peptides (3, 5 and 6 amino acids) surrounding 3 of the 4 cysteines, which makes the peptides 
unsuitable for detection using mass spectrometry. Instead, CREB cysteine to serine mutant constructs 
were generated, and S-nitrosylation of the mutants was tested. CREB cysteines are located in the 
alpha domain (C90) and in the C-terminal bZIP domain that is important for CREB homodimerization 
and binding to DNA (C300, C310 and C337) (Fig.4A). Single mutants of C90, C300, C310 or C337 
failed to reduce S-nitrosylation in CysNO-treated HEK293 cells, as did mutation of C300 and C310. 
However, triple mutation of C300, C310 and C337 led to a reduction in CREB S-nitrosylation 
(Fig.4B). CREBC300/310/337S was still phosphorylated at serine 133 in response to forskolin, suggesting 
that despite the mutations, the integrity of the protein and the ability to respond to intracellular 
signaling was preserved (Fig.S6). 
SNO-peptide analysis identified C166 as the site of S-nitrosylation of RBBP7 (Table S13, hit 
number 238). C166 was previously identified as a potential site of S-nitrosylation on RBBP7 (24), 
however this finding had not been confirmed in intact cells. We generated a vector expressing a 
mutant form of RBBP7 carrying C166S mutation and found that S-nitrosylation of RBBP7 was 
abolished in CysNO-treated HEK293T cells (Fig.4C and Fig.4D). Since RBBP7 is closely related to 
RBBP4 (89.2% identical, 94.6% similar; Fig.S7A), we mutated the conserved cysteine in RBBP4 and 
found that this event also led to decrease S-nitrosylation (Fig.S7B). Because RBBPs function as 
scaffolding subunits for NuRD complexes, it is possible that S-nitrosylation provides a mechanism to 
regulate the assembly and stability of the complex. 
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NO regulates RBBP7 binding to CHD4 
RBBP7 contains 7 WD (tryptophan-aspartic acid)-repeat regions, which provide platforms for 
protein binding and form a beta helical propeller structure (25). C166 of RBBP7 is within WD repeat 
2 (Fig.4C), therefore we reasoned that S-nitrosylation may regulate the interaction of RBBP7 with 
other subunits within chromatin remodelling complexes. We first investigated whether S-nitrosylation 
of RBBP7 influences its interaction with other NuRD subunits by performing pull down experiments 
on cortical neurons. Strikingly, treatment with CysNO resulted in increased binding of RBBP7 to the 
ATPase subunit CHD4 (Fig.5A). To test whether the interaction depends on nitrosylation of RBBP7 
at C166, FLAG-CHD4 was transfected with either HA-RBBP7WT or HA-RBBP7C166S in HEK293T 
cells, and the interaction was studied using pull down assay. We observed that CysNO increased 
CHD4 binding to RBBP7 (Fig.5B), and this effect depended on RBBP7 nitrosylation at C166. Thus, 
S-nitrosylation of this cysteine regulates the interaction between at least two subunits within the 
NuRD complex, perhaps determining its assembly on chromatin.  
 
S-nitrosylation of RBBP7 promotes dendritogenesis in cortical neurons 
In cortical neurons, NO signalling enhances dendritogenesis (26) by S-nitrosylating the RBBP7-
interacting protein HDAC2 on C262 and C274 (4). We therefore investigated whether S-nitrosylation 
of RBBP7 may contribute to this process. Mouse embryonic cortical neurons were maintained under 
depolarising conditions with KCl (50 mM) for 2 days, and dendritic complexity was assayed using 
Sholl analysis. Knockdown of RBBP7 alone did not inhibit KCl-induced dendritogenesis (Fig.S8A-
B), possibly due to the fact that the RBBP7 paralog RBBP4, S-nitrosylated at the conserved cysteine 
(Fig.S7B), and may be functionally compensating for RBBP7. Indeed, knockdown of both RBBP7 
and RBBP4 led to a remarkable reduction of dendritic growth (Fig.5C and Fig.S8C). Strikingly, this 
effect was rescued by co-transfection of a rescue construct expressing RBBP7WT but not RBBP7C166S, 
indicating that S-nitrosylation of RBBP7 is required for dendritogenesis in vitro (Fig.5C and 
Fig.S8D). 
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Discussion 
In this study, we identified the nuclear SNO-proteome of rat cortical neurons. To our knowledge, 
this is the first comprehensive screen of nuclear targets of S-nitrosylation performed in mammalian 
cells. Identification of nuclear proteins in previous studies (12-14) may have been limited by the low 
abundance of nuclear proteins relative to cytoplasmic, which renders nuclear targets of S-nitrosylation 
less amenable for detection. To circumvent this limitation, we assayed nuclear extracts of cortical 
neurons exposed to the NO-donor CysNO. This technical approach yielded 614 putative targets of S-
nitrosylation that are suitable for further investigation.  Known intracellular targets of S-nitrosylation 
in neurons were identified in our study, including GAPDH (10), HDAC2 (4, 9) and nucleophosmin 
(27). It should be noted however that our CysNO-responsive dataset may have missed some 
intracellular targets of S-nitrosylation, given that  similar to other biotin switch- related 
methodologies, the SNORAC allows the identification of a subset of S-nitrosylated proteins (28). 
Proteins involved in the regulation of gene expression and neuronal development were 
overrepresented in S-nitrosylated nuclear samples. We previously showed that S-nitrosylation of 
HDAC2 promotes the expression of genes necessary for neuronal radial migration during mouse 
embryonic development (4, 8). nNOS levels increase drastically when cortical layers are formed (7, 
8), therefore additional nuclear proteins may be targeted by S-nitrosylation at these time points to 
regulate corticogenesis. As an initial step towards exploring this possibility, proteins involved in the 
regulation of gene expression were subject to further investigation.  Both the transcription factor 
CREB and the histone binding protein RBBP7 were S-nitrosylated in cortical neurons following 
depolarisation. How S-nitrosylation affects CREB function is unknown, however mutation of the 
cysteines within bZIP domain (C300, C310 and C337) has been shown to affect binding of the 
coactivator CRTC2 (29).  We found that S-nitrosylation of RBBP7 at cysteine 166 is required for 
activity-dependent dendritogenesis. The implications of this finding may be far-reaching, given that 
disruption of dendritogenesis at early developmental stages impacts on adult dendritic morphology 
and causes an aberrant response to fear conditioning (30). Our data also indicate that S-nitrosylation 
of RBBP7 may play a role in regulating subunit composition of the NuRD complex. S-nitrosylation of 
RBBP7 promotes its interaction with the NuRD ATPase subunit CHD4, an event that is especially 
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relevant during corticogenesis when NuRD complexes undergo a developmentally-regulated subunit 
switch (21). We previously showed that the mutual inclusion of CHD subunits within the NuRD 
complex determines the expression of specific sets of genes during mouse cortical development (21). 
Intriguingly, S-nitrosylation could represent a key regulatory mechanism shared by most NuRD 
subunits that may regulate their assembly on chromatin. How S-nitrosylation affects protein 
conformation of NuRD subunits is unknown, however recent reports suggest that S-nitrosylation may 
promote disulphide bond formation within and between proteins, thereby inducing structural changes 
which can outlast that of the initial S-nitrosylation event (31, 32). Thus it is possible that transient S-
nitrosylation of the NuRD complex may induce disulphide bond formation that will have long-term 
effects on the complec subunit composition and, as a result, on  gene expression . 
GO analysis of S-nitrosylated nuclear proteins revealed that metabolic proteins are especially 
modified by S-nitrosylation. This finding is in agreement with a previous S-nitrosoproteome analysis 
of adult mouse brain that found several metabolic pathways targeted by S-nitrosylation (13). Although 
the role of S-nitrosylation on nuclear metabolism in mammalian cells is unknown, an effect has been 
shown in plants, where many nuclear proteins are S-nitrosylated in response to pathogen signalling in 
plants (33). Moreover, during plant stress responses, S-nitrosylation of the protein arginine N-
methyltransferase 5 (PMRT5) promotes dimethylation of the spliceosome and pre-mRNA splicing of 
stress-response genes (34). The function of chromatin remodelling complexes, including NuRD, is 
affected by the availability of metabolically-generated cofactors (35). Thus, S-nitrosylation of 
proteins involved in both nuclear metabolism and gene expression may be functionally linked in 
neurons. 
Here, we identified 4 lysine-containing motifs that may render cysteines more susceptible to S-
nitrosylation. Previous work suggested that acidic and basic residues located in the vicinity of 
cysteines render nitrosylation more chemically favourable in these regions (22, 23). In macrophages, 
specific S-nitrosylation motifs have been shown to guide the interaction between donor and acceptor 
proteins required for trans-nitrosylation (36) yet similar trans-nitrosylation motifs have yet to be 
identified in neurons. Here, we found that our newly identified lysine motifs are essential for S-
nitrosylation of both MBD3 and HDAC2. The lysine motif 2 (……C…..K) has previously been 
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identified in a screen on GSNO-treated heart homogenates (24), but was been functionally 
characterised. Indeed, the mechanisms through which lysine motifs regulate S-nitrosylation of MBD3 
and HDAC2 are currently unknown, however a recent bioinformatic analysis suggested that cysteines 
in close proximity to ubiquitinated lysines are more likely to be modified by S-nitrosylation (37), 
hinting at a possible interplay between cysteine S-nitrosylation and post-translational modifications at 
neighbouring residues.  Our screen provides targets of nuclear S-nitrosylation in cortical neurons, the 
site(s) of S-nitrosylation for most identified proteins and characterise for the first time, lysine- motifs 
that regulates cysteine S-nitrosylation. Further investigation of the S-nitrosylated proteins identified in 
our screen will be needed to reveal the full impact of NO signalling on nuclear functions in 
developing neurons. 
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Materials and Methods 
Animal Procedures 
All animal experiments were approved by the UCL Animal Welfare and Ethical Review Body and 
carried out in accordance to appropriate UK Home Office licenses. Timed pregnant Sprague Dawley 
rats and C57BL/6J WT mice were used to prepare embryonic cortical neurons. 
Preparation of cortical neurons 
E17 rat cortices were isolated in cold dissection buffer (1x HBSS, 2.5mM Hepes pH 7.4, 30 mM D-
glucose, 1 mM CaCl2, 1 mM MgSO4, 4 mM NaHCO3) and digested in digestion buffer (1 mM Hepes 
pH 7.4, 20 mM glucose, 82 mM Na2SO4, 30 mM K2SO4, 6mM MgCl2, 0.25mM CaCl2, 0.001% 
Phenol Red, 0.126mM NaOH) plus 200 units papain activated with cysteine-HCL and neutralised to 
pH 7. Cortices were washed, dissociated and plated in plating media (MEM with 10% FBS, 5% HS 
and 1 mM glutamine). Cells were plated on 10 cm Nunc plates coated with 20 μg/ml poly-D-lysine 
and 2 μg/ml laminin at 12.5 million per dish and kept at 37°C, 5% CO2. After 1 day in culture, media 
was replaced with supplemented neurobasal (NB with 1x B27, 1 mM glutamine, 1x penicillin-
streptomycin and 10 μM FdU). Prior to stimulation, cells were starved for 16h by replacing 2/3 of 
media with neurobasal without B27 (1 mM glutamine, 1x penicillin-streptomycin and 10 μM FdU). 
E15.5 mouse cortices were isolated and digested as for rat cortices. Cells were plated on coverslips in 
24 well plates coated with 40 μg/ml poly-D-lysine and 2 μg/ml laminin at 0.35 million per well and 
kept at 37°C, 5% CO2. 
Cell culture and transfections 
HEK293T cells (ATCC® CRL-11268™) and Neuro2a cells (ATCC® CCL-131™) were cultured 
according to standard conditions. Cells were transfected using Lipofectamine 2000 in OptiMEM 
according to manufacturer’s guidelines. 
 
Biotin Switch Technique 
S-nitrosylation is light sensitive and light can also react with ascorbate to induce artifactual signals, 
therefore all procedures involving detection or stimulation of S-nitrosylation were carried out in 
minimal light conditions using brown eppendorf tubes and foil covered polypropylene falcon tubes. 
No glassware/metalware was used to avoid contaminating metal species that could interfere with the 
reaction (38, 39). CysNO was prepared as previously described (40). Cys only was prepared as for 
CysNO, using BPC-grade water (Sigma W3513) in place of NaNO2. Buffers were prepared as in (15) 
with additional buffers used as specified. 
 
For neuronal samples, 3 x 10cm plates of E17 cortical neurons per sample were treated as appropriate. 
For HEK experiments, a transfected 6cm plate of HEK293T cells was treated per condition. Cells 
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were washed twice with ice cold PBS and harvested in cold HEN lysis buffer (100 mM Hepes, 1 
mM EDTA, 0.1 mM neocuproine, pH 8.0 with 0.2% NP40). Samples were then homogenized 5 
times with a 25-gauge needle, centrifuged for 10 min 10,000g 4°C and supernatant collected 
(neuronal samples contained ~1.2 mg of protein per 3 plates, HEK293T cells 650 μg of protein per 
sample). Except for experiments in Fig 2 that were lysed and blocked immediately, low molecular 
weight S-nitrosothiols were removed by acetone precipitation -20°C for >1h, followed by 
centrifugation of protein pellets for 20 min 2,000g 4°C, 2 washes with 70% acetone, and resuspension 
in 200μL HENS (100 mM Hepes, 1 mM EDTA, 0.1 mM neocuproine, pH 8.0  with 1% SDS). 
Samples ere blocked by adding an equal volume of 2X MMTS Blocking Buffer (2% MMTS, 5% SDS 
in HEN buffer) and incubated for 30 min at 50 °C with intermittent vortexing. Protein pellets were 
precipitated and as before, then washed 3 times with 70% acetone and resuspended in 220 μL HEN 
lysis buffer. Sodium ascorbate was added to a final concentration of 50mM and samples incubated for 
5 min at RT with gentle mixing. Biotin HPDP (Thermo 21341) was added to 1 mM and samples 
rotated for 45 min, followed by acetone precipitation as above. Following 3 washes with 70% 
acetone, samples were resuspended in 220 μL HENS and 400 μL neutralization buffer added. 
Samples were precleared by incubation with protein A beads for 1h at RT, then centrifuged 500 g 5 
min RT and supernatant removed. 10% total inputs were taken, and samples incubated with 30μL 
bead volume of streptavidin agarose beads overnight rotating at 4°C. Samples were then centrifuged 
for 500g 5 min 4°C, and washed 4 x in wash buffer (neutralization buffer 600 mM NaCl). Beads were 
dried using a 29G needle and 40μL of 2x western loading buffer (2% SDS, 2% βME, 20% glycerol, 
100 mM Tris 6.8, 0.008% bromophenal blue) was added. Samples were then boiled for 5 min, then 
centrifuged 10,000g 2 min RT and supernatant run on homemade 10% polyacrylamide gels or precast 
NuPage 4-12% Bis-Tris gels (NP0335). For biotin switch on treated cellular lysates, the above 
protocol was followed, except treatment took place post harvesting in samples made up to 500μL with 
HEN buffer. In experiments using NEM blocking (140 mM in HEN buffer with SDS at 2.44%), 
blocking was carried out for 45 min at 50 °C. 
SNORAC  
Nuclear and cytoplasmic protein extractions of E17 neurons were carried out using the NE-PER kit 
(Thermo, cat no: 78833) as per the manufacturer’s instructions, with an extra wash with CER1 prior 
to addition of buffer NER. 400 μg of protein was used per sample. CysNO treatment for 20 min was 
carried out in the CER1 (cytoplasmic) or NER1 (nuclear) buffer with intermittent mixing. CysNO was 
removed after treatment either by acetone precipitation or using P6 spin columns prewashed in HEN 
buffer. Protein amounts were equalized by BCA assay then volume made up to 500μL with HEN 
buffer. SNORAC was carried out according to (15) with the following modifications. Thiopropyl 
sepharose 6B resin (GE Healthcare, 17-0420-01) was used, after 3 washes in BPC water and 1wash in 
HEN buffer. Beads were centrifuged at 500 g 10 min 4°C in between washes. Beads were stored (no 
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longer than 1 day) at in HEN buffer at 4°C in a 1:1 ratio. Mass spectrometry samples were frozen with 
HEN buffer diluted 10 fold in water and stored at -20°C. 
 
Silver staining 
Standard silver staining protocol was followed. Briefly, the polyacrylamide gel was soaked in 50% 
methanol 2 x 15 min then 5% methanol for 10 min before rinsing in water. Gel was then soaked in 10 
μM DTT for 20 min and then in 0.1% silver nitrate for 20 min. After 3 washes with water, gel was 
washed 2x in developer solution (500 mL ~285 mM sodium carbonate solution plus 250 μL 37% 
formaldehyde) and soaked until bands became visible. The reaction was stopped with addition of 
citric acid and gel washed in water before imaging. 
 
Co-IP protocol 
Co-immunoprecipitation experiments were performed in low light conditions (see sample guidelines 
for working with S-nitrosylation (39)). For neurons: 1x 10cm plate used per condition. Cells were 
treated with 200 μM CysNO donor or Cys control for 20 min and then washed with cold PBS and 
harvested in cold IP Lysis buffer (50mM Tris pH 7.4, 150mM NaCl, 1% TX100, 1% Sodium 
Deoxycholate) containing a protease inhibitor cocktail, phosphatase inhibitors 2 and 3 and PMSF (all 
at 1:100). Samples were lysed on ice for 30 min and homogenized and then cleared by centrifugation 
at 1000xg for 10 minutes at 4°C. Lysates were pre-cleared with protein G-Sepharose beads (GE 
healthcare, 17-0618-01) for 2 hrs at 4°C. Total inputs were taken. The remaining sample was 
incubated overnight 4°C with rabbit anti-CHD4 (ab72418) or rabbit IgG (Dako X0903). Lysates were 
then incubated with protein G–Sepharose beads for 2 hours at 4°C. Beads were washed 1x time with 
wash buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.1% TX100, 5% glycerol, protease and 
phosphatase inhibitors at 1:1000), 2x with wash buffer and 2 x PBS. Excess PBS was removed and 
proteins eluted by boiling the beads with 2x Western loading buffer. Total Inputs and samples were 
then run on precast 3-8% Tris-Acetate gels. For HEK293T: 6 cm plates of HEK293T cells were 
cotransfected with Flag mCHD4 and either HA-RBBP7WT or HA-RBBP7C166S. HEK 293T cells were 
treated as for E17 neurons then washed with cold PBS and harvested in cold RIPA buffer (50 mM 
Tris pH 7.5, 150 mM NaCl, 1% NP40, 0.5% Deoxycholate) containing inhibitors as above at 1:100. 
Samples were lysed and cleared then protein concentration was determined using BCA Protein Assay; 
250-400 μg of protein was used per experiment. Lysates were pre-cleared and total inputs were taken. 
Remaining sample was incubated overnight in the dark 4°C with rabbit anti-HA (CST 3724S) or 
rabbit IgG (Dako X 0903). Lysates were then incubated with protein G–Sepharose beads for 2 hours 
at 4°C. Beads were washed and proteins eluted as for E17 samples. Samples were then run on precast 
NuPage 4-12% Bis-Tris gels. 
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Western blotting  
Western blot was carried out according to standard procedures. Transfer conditions were 100V for 
3hrs at 4°C in 10% methanol for experiments involving detection of high MW proteins and were 
330mA for 1 hr 30 in 20% methanol for routine transfers. Membranes were blocked in 5% 
Milk/TBST prior to overnight incubation at 4°C with primary antibodies at a 1:1000 dilution. The 
following primary antibodies were used: mouse anti-C-Myc (A7 Santa Cruz Sc-56634), mouse anti-
Flag (M2 Sigma F3165), mouse anti-HA (Biolegend 901502), rabbit anti-HA (Cell Signaling, 3724), 
mouse anti-HDAC2 (Merck Millipore 05-814), mouse anti-HSP90 (Abcam Ab13492), rabbit anti-
RBBP4 (Abcam 79416), rabbit-RBBP7 (Sigma R4279), goat anti-HSP90 (Santa Cruz Sc-1055), 
rabbit anti-CREB (CST 9197), phospho-CREB ser133 (CST 9191S). Post TBST washes, membranes 
were incubated with the appropriate secondary antibody at a 1:20000 dilution. Secondary antibodies: 
anti-mouse HRP GE Healthcare NXA931, ant- goat HRP Sigma A5420, anti-rabbit HRP GE 
Healthcare NA93AV. Signal was detected using ECL or ECL Prime detecting reagents (GE 
Healthcare Life Sciences) and by exposing the immunoblot to the Amersham Hyperfilm (GE 
Healthcare Life Sciences). 
 
Dendritogenesis assay 
E15.5 mouse neurons were transfected using Lipofectamine 2000 2 hr post plating, with 220 ng Pbird 
GFP with 500  ng of either mycEV, mycRBBP7WT siRNA resistant or mycRBBP7C166S siRNA 
resistant plasmids. Cells were co-transfected with 400nM of each siRNA. Media was changed 3 hr 
post transfection to Neurobasal media supplemented with 0.33% B27, 1 mM glutamine, 1x 
penicillin-streptomycin and 10 μM FdU, and coverslips fixed in 4% PFA/PBS 48 h post 
transfection. Coverslips were washed 1x PBS, permeablised in 0.3% Triton-X/PBS and blocked in 
5% NGS 5% FBS/ PBS for 1 hr RT, and incubated with chicken anti-GFP (Abcam ab13970) 
overnight. After 3 PBS washes, samples were incubated with Dapi and Alexa Fluor goat anti-chicken 
488 (Life Technologies A-11039) at 1:1000 for 1hr RT. Coverslips were washed and mounted. Slides 
were then blinded prior to imaging and analysis. Images were acquired using SPE or SPE3 confocal 
microscope (Leica) with LAS AF software and processed using ImageJ/Fiji. Sholl analysis was 
performed using Image J Simple Neurite Tracer (Fig.S8) or Fiji sholl analysis plugin (Fig.4), and 
samples de-blinded after final processing.  
 
Plasmids 
The CMV myc-CREB plasmid was created by Bonnie Lonze (Ginty Lab). msMBD3, ratRBBP4 and 
ratRBBP7 were subcloned into the CMV-myc expression vector. Mutagenesis to create RBBP7, 
RBBP4 and MBD3 cystine-to-serine mutants, MBD3 lysine-to-alanine, and mycRBBP7WT and 
mycRBBP7C166S siRNA resistant plasmids was carried out using Quikchange multisite-directed 
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mutagenesis kit (Agilent). HA-tagged ratRBBP7 and HA-tagged msHDAC2 were each cloned into 
Adeasy pshuttle CMV vectors, and cysteine and lysine mutants created using Quikchange multisite-
directed mutagenesis kit (Agilent). Flag mCHD4, hCHD5 and hCHD3 were generated as previously 
described (21). SiRNAs were generated by Invitrogen. Sequences: siRBBP7 (5’-3) CCA CAU AAU 
GAA ACU AUU CUG GCU U and the reverse complement (5’-3’) AAG CCA GAA UAG UUU 
CAU UAU GUG G. siRBBP4: (5’-3’) AAA UCU UUC CCU UCA GGC CUG GUC A and the 
reverse complement (5’-3’) UGA CCA GGC CUG AAG GGA AAG AUU U. 
 
Statistical Analysis  
Statistical analysis was performed as indicated in figure legends. All analysis was performed using 
GraphPad Prism Software (Version 7.0a). 
 
Gene Ontology Analysis  
Neuronal screens: Classifications listed on tables assigned from Uniprot by Proteome Discoverer 1.4 
(Thermo Fisher Scientific, Bremen, Germany). All other gene ontology analysis was carried out using 
PANTHERdb (pantherdb.org) and version number listed in the respective figure legend. 
 
Overrepresentation Analysis: PANTHER Overrepresentation Test (release 20170413) with 
Bonferroni correction for multiple testing. For Figure S2. nuclear protein background dataset (Table 
S7) was used as background dataset. 
 
Mass Spectrometry  
 
CysNO-treated neuronal extracts (1mM CysNO) 
 
Exp. 1 
A1. 1 mM Cys 
A4. 1 mM CysNO 
A5. 1 mM CysNO without ascorbate  
Exp. 2 
B1. 1 mM Cys 
B2. 1 mM CysNO 
B4. 1 mM CysNO without ascorbate 
 
Beads thawed at 4 °C, centrifuged 4000 rpm 1min RT. Supernatant was digested at 37 °C with 800 ng 
of trypsin proteomics grade (Sigma) in 100 μL of 100 mM tris buffer, pH 8.5 (buffer A). Following 
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tryptic digestion, supernatants were recovered. Beads were washed three times with 20 mM 
ammonium bicarbonate in 50% MeOH (v/v) (buffer B). Ammonium bicarbonate washes were pooled, 
dried, then combined with the first supernatant. 
 
Quantitative analysis: Digested proteins samples were subjected to O18 labelling as in (41). 30 μL 
aliquots of A-4, A-5, B-1, B-2 were dried and resuspended in 50  μL of H2O18 98% pure (Sigma) / 
methanol 4:1 (v/v). Solution was then buffered by the tris buffer. A fresh trypsin aliquot (200 ng in 
0.5 μL) was added in order to catalyse the oxygen exchange reaction, which was allowed to proceed 
overnight at 37 °C. 30 μL aliquots of A-1, A-4, B-2, B-4 were dried, resuspended in 30  μL of normal 
HPLC water, and subjected to a parallel trypsin-catalysed oxygen exchange reaction. Even though no 
change in the molecular weight of control peptides (“light” (L) peptides) was produced, the reaction 
was allowed to proceed in parallel to the “heavy” (H) labelling reaction in order to avoid any possible 
source of bias. After labelling, to inactivate trypsin and avoid the phenomenon of back-exchange, 
samples were heated for 1 h at 56 °C and boiled for 10 min at 100 °C. Labelled samples were mixed 
in a 1:1 ratio as follows: A-4(H):A-1(L); A-5(H):A-4(L); B-2(H):B-4(L); B-1(H):B-2(L). This 
arrangement allowed the relative comparison of proteomes isolated from CysNO-treated cells versus 
untreated cells and CysNO-treated cells versus CysNO minus ascorbate-treated cells, in duplicate 
analysis with forward/reverse labeling. Mixed samples were purified by strong cation exchange 
(SCX) StageTips (42). Peptide mixtures were diluted with 1.5 mL of 80% acetonitrile / 0.5% formic 
acid (solution SCX-a) and loaded onto a 200 μL micropipette tip stacked with one layer of a strong 
cation exchange resin (Empore extraction disks, Sigma) previously conditioned with 20  μL of 
solution SCX-b (20% acetonitrile / 0.5% formic acid) and 20  μL of solution SCX-a. After two 
washing steps (20 μL of solution SCX-a, 20 μL of solution SCX-b), elution of tryptic peptides was 
achieved by adding 7  μL of 500 mM ammonium acetate / 20% acetonitrile (solution E). The eluate 
was dried and resuspended in 15 μL 0.1% formic acid / 2% acetonitrile. A 5 μL aliquot of each 
sample was subjected to nanoLC-MS/MS analysis. 
 
CysNO treated neuronal extracts (200μM CysNO) 
 
Exp 3 
C7. 200μM Cys 
C8. 200μM CysNO 
C9. 200μM CysNO without ascorbate 
 
Exp 4 
E1. 200μM Cys 
E2. 200μM CysNO 
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E3. 200μM CysNO without ascorbate 
 
Beads thawed at 4 °C, centrifuged at 4000 rpm 1 min RT. Supernatant was removed and digested at 
37 °C with 300ng of trypsin proteomics grade (Sigma) in 100 μL of 100 mM TEAB buffer, pH 8.5 
(buffer C). Following tryptic digestion, the supernatants were recovered and the beads were washed 
three times with 20 mM TEAB in 50% MeOH (v/v) (buffer D). The washes and the first supernatant 
of each sample were pooled, dried and resuspended in 100 μL of buffer C (samples: SNO-proteins). 
Proteins were reduced further by adding 10 μL of 100 mM DTT (1h at 37 °C) and residual free 
cysteines were alkylated by adding 12 μL of 200 mM iodoacetamide. After quenching the reaction 
with additional 2 μL of 100 mM DTT, complete overnight digestion was achieved by adding a new 
300 ng aliquot of trypsin. Samples were labelled according to the standard dimethyl labelling 
procedure (43). Briefly, samples were subjected to reductive amination by adding 4 μL of 0.6 M 
sodium cyanoborohydride and 4 μL of either formaldehyde (4% w/v, “light” label) or formaldehyde-
d2 (4% w/v, “medium” label). Samples were labelled as “light” (L) or “medium” (M) and mixed in 
pairs according to the Table A. 
 
Table A: labelling scheme for dimethyl labelling experiment and generation of M:L pairs 
Sample Label M:L pairs 
C-7. NUC cys L 
80 μL of C-7 (L) + 80 μL of C-8 (M) 
80 μL of C-9 (L) + 80 μL of C-8 (M) 
C-8. NUC CysNO M 
C-9. NUC CysNO - asc L 
E-1. NUC cys L 
80 μL of E-1 (L) + 80 μL of E-2 (M) 
80 μL of E-3 (L) + 80 μL of E-2 (M) 
E-2. NUC CysNO M 
E-3. NUC CysNO - asc L 
 
Digest pairs were diluted to 2.4 mL with SCX-a solution and purified by SCX StageTips as described 
above. The six eluates were evaporated and peptides resuspended in 12 μL 0.1% formic acid / 2% 
acetonitrile. A 4 μL aliquot of each sample was subjected to nanoLC-MS/MS analysis with technical 
duplicates (2 injections per sample).  
 
Exp 5 
Nuclear extracts 
1. 200μM Cys 
2. 200μM CysNO 
Cytoplasmic extracts 
3. 200μM Cys 
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4. 200μM CysNO 
 
SNO-proteins were isolated as described in Experiment 1. Digested proteins were prepared and 
labelled by O18 as described above, with minor modifications in starting amounts of samples subjected 
to isotopic labelling. As before, the volume of the supernatant + evaporated washes recovered from 
on-beads digestion was 100 μL. Starting amounts for the “heavy” labelling reaction were: 45 μL for 
samples 1 and 2; 25  μL for samples 3 and 5; 2 x 25  μL for sample 4. Exactly the same amount for 
each of the five samples was taken for the “light” labelling reaction.  
 
Labelled samples were mixed in a 1:1 ratio as follows: 1(H):2(L); 1(L):2(H); 4(H):3(L); 3(H):4(L). 
Mixed samples were purified by strong cation exchange (SCX) StageTips as described in Exp 1. 
Because of the higher amount of protein sample recovered in this experiment, sample fractionation at 
the peptide level could be achieved (4 fractions). Thus, after tip conditioning, sample loading and 
washing, stepwise elution of tryptic peptides was achieved by sequential addition of 7 μL of four 
solutions, all containing 20% acetonitrile, of increasing ionic strength and pH: (i) 60 mM ammonium 
acetate, 0.5% formic acid; (ii) 120 mM ammonium acetate, 0.5% formic acid; (iii) 250 mM 
ammonium acetate, 0.5% formic acid; (iv) 500 mM ammonium acetate. The four SCX fractions were 
evaporated by vacuum centrifugation and resuspended in 8 μL of 0.1% formic acid / 2% acetonitrile. 
A 6 μL aliquot of each fraction (4 fractions x 6 H:L pairs) was subjected to nanoLC-MS/MS analysis.  
 
SNO-site identification  
To elute formerly cys-nitrosylated peptides still covalently attached to the beads after on-bead 
digestion of SNO-proteins, 100 μL of buffer B were added to each sample, followed by the addition 
of 10 μL of 100 mM DTT (incubation for 1 h at 37 °C). Alkylation of released cysteines was achieved 
by adding 10 μL of 200 mM iodoacetamide (1h at 37 °C in the dark). The supernatants were 
recovered, and the beads were washed with 50 μL of buffer B. Supernatants and their respective 
washes were pooled and evaporated in a vacuum centrifuge (samples: SNO-peptides). For a 
qualitative analysis of putative nitrosylation sites, SNO-peptides from the evaporated extracts were 
dissolved in 200 μL of solution SCX-a, purified by SCX StageTips as described, evaporated to 
dryness and reconstituted in 10 μL of 0.1% formic acid / 2% acetonitrile. A 5 μL aliquot of the pooled 
sample was subjected to nanoLC-MS/MS analysis. Peptides detected in the CysNO dataset of 
experiment 5 were assigned to proteins present in the SNO-protein dataset (biological n of ≥3). Of 
note, shared peptides that were detected in both Cys and CysNO conditions were also included in our 
combined dataset (Table S13). 
 
Protein identification of total inputs in neuronal extracts 
Neuronal nuclear protein extracts (50 μg) were precipitated by adding cold acetone (4:1 v/v) and 
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incubating the solution for 1 h at -20 °C. The pellet was solubilized in 50 μL of 5% sodium 
deoxycholate (DOC) containing 60 mM tris buffer (pH 8.8). Cysteine alkylation was achieved by 
adding sequential aliquots of, respectively, 5 μL of 100 mM DTT (1 h incubation at 37 °C), 6 μL of 
200 mM iodoacetamide (1 h incubation at 37 °C), 1 μL of 100 mM DTT (20 min incubation at 37 °C). 
Solution volume was brought to 500 μL by adding 20 mM tris buffer. Overnight protein digestion was 
allowed to proceed at 37 °C after adding sequencing grade trypsin (Sigma, 1:100 w/w). The 
enzymatic reaction was quenched by the addition of 50 μL of 5% trifluroacetic acid, which served 
also for precipitating the DOC detergent. After spinning down the precipitate on a bench centrifuge, 
200 μL of the supernatant were removed and purified on RP StageTips as described in previous 
paragraphs. Finally, the purified peptide mixture was fractionated on SCX StageTips as described 
above. Stepwise elution of tryptic peptides from SCX StageTips was achieved by sequential addition 
of 20 μL of seven solutions, all containing 20% acetonitrile, of increasing ionic strength and pH: (i) 
50 mM ammonium acetate, 0.5% acetic acid; (ii) 75 mM ammonium acetate, 0.5% acetic acid; (iii) 
100 mM ammonium acetate, 0.5% acetic acid; (iv) 150 mM ammonium acetate, 0.5% acetic acid; (v) 
250 mM ammonium acetate, 0.5% acetic acid; (vi) 350 mM ammonium acetate, 0.5% acetic acid; 
(vii) 500 mM ammonium acetate. Fractions were evaporated by vacuum centrifugation and 
resuspended in 15 μL of 0.1% formic acid / 2% acetonitrile. A 2 μL aliquot of each fraction was 
subjected to nanoLC-MS/MS analysis using a long elution gradient (see below).  
 
nanoLC-MS/MS analysis for neuronal extracts 
Chromatography was performed on an Easy LC 1000 nanoscale liquid chromatography (nanoLC) 
system (Thermo Fisher Scientific, Odense, Denmark). The analytical nanoLC column was a pulled 
fused silica capillary, 75 μm i.d., in-house packed to a length of 10 cm with 3 μm C18 silica particles 
from Dr. Maisch (Entringen, Germany). The peptide mixtures were loaded at 500 nL/min directly 
onto the analytical column. A binary gradient was used for peptide elution. Mobile phase A was 0.1% 
formic acid, 2% acetonitrile, whereas mobile phase B was 0.1% formic acid, 80% acetonitrile. 
Peptides were separated by a gradient elution at a 300 nL/min flow rate, ramping from 5% B to 35% 
B in 60 min (50 min for SNO-peptides, 120 min for nuclear extracts), and from 35% B to 100% B in 
additional 15 min; after 5 min at 100% B, the column was re-equilibrated at 2% B for 10 min before 
the following injection. MS detection was performed on a quadrupole-orbitrap mass spectrometer Q-
Exactive (Thermo Fisher Scientific, Bremen, Germany) operating in positive ion mode, with 
nanoelectrospray (nESI) potential at 1800 V applied on the column front-end via a tee piece. Data-
dependent acquisition was performed by using a top-12 method (top-8 for SNO-peptide), where the 
twelve most abundant ions were automatically selected for HCD fragmentation at normalized 
collision energy of 25%. Resolution (FWHM), AGC target and maximum injection time (ms) for full 
MS and MS/MS were 70,000/17,500, 1e6/1e5, 20/60, respectively. MS/MS parameters for detection 
of SNO-peptides were: resolution 35,000; AGC target 2e5, max injection time 120 ms. MS full scan 
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range was 350-1800 m/z. Mass window for precursor ion isolation was 1.6 m/z. Ion threshold for 
triggering MS/MS events was 5e4. Dynamic exclusion was 30 s.  
 
Data analysis for neuronal extracts 
Protein identification and quantification was achieved in Proteome Discoverer 1.4 (Thermo Fisher 
Scientific, Bremen, Germany), using Sequest as search engine and the RATTUS proteome sequence 
database (http://www.ebi.ac.uk/uniprot) accessed on March 2015. The database was merged with a 
list of common contaminants named “Common Repository of Adventitious Proteins” retrieved from 
The Global Proteome Machine website (http://www.thegpm.org/crap/index.html). In total, 27,927 
entries were searched. The following general search parameters were used: MS tolerance 15 ppm; 
MS/MS tolerance 0.02 Da; enzyme trypsin; max. missed cleavages 2; variable modification: oxidised 
methionine. Additionally, the following search parameters were used, depending on Experiment 
number: Exp 1 and 2) variable modification: C-terminal 18O labelling; fixed modification: methyl 
thio-cysteine (MMTS); Exp. 3 and 4) variable modifications: N-ethylmaleimide-cysteine (NEM), 
scarbamidomethyl-cysteine (CAM); fixed modifications (in two parallel searches): (a) N-ter dimethyl 
(light); dimethyl-lysine (light); (b) N-ter dimethyl (medium); dimethyl-lysine (medium). Exp. 5) 
variable modification: C-terminal 18O labelling; fixed modification: N-ethylmaleimide-cysteine 
(NEM); For SNO-peptide searches, the following additional parameters were used: Exp. 1 and 5) 
fixed modification: carbamidomethyl-cysteine (CAM). False discovery rate estimation was performed 
in Proteome Discoverer using the Target-decoy validator node. Minimum requirement for protein ID 
for every experiment was 2 peptides at 95% confidence, whereas for SNO-peptide identification 
peptide confidence threshold was set to 99%. 
 
 
Hit criteria for SNO-Ps 
In order to be considered a target for S-nitrosylation, proteins detected from mass spectrometry had to 
be enriched ≥ 2 fold in CysNO samples versus control in 3 experiments and not enriched ≥ 2 fold in 
any control. Sodium ascorbate is required as a reducing agent for S-nitrosothiols, therefore samples in 
which sodium ascorbate were omitted were used as negative controls (See Table S2). 
 
Motif-X analysis 
Motif-X (motif-x.med.harvard.edu) (44, 45). Foreground: SNO-peptides associated with S-
nitrosylated protein hits. Settings: Extended from IPI Rat Proteome, central character: C, width: 21, 
significance: 0.000001. Background: IPI Rat Proteome, background central character: C. 
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Figure 1 
 
Fig. 1. Identification of S-nitrosylated nuclear proteins using SNORAC. (A) Nuclear extracts 
from E17 cortical neurons were treated with CysNO and S-nitrosylated proteins captured using 
SNORAC. Resin-bound proteins were trypsinised and eluted fragments analysed by quantitative mass 
spectrometry to identify proteins enriched in CysNO-treated groups. A second elution step was 
carried out using DTT, releasing fragments containing the previously S-nitrosylated cysteines and 
allowing the identification of S-nitrosylation sites (SNO-sites). (B) Silver stain of proteins isolated 
using SNORAC, and HDAC2 western blotting on SNORAC eluates and total inputs. Sodium 
ascorbate is required for isolation of S-nitrosylated proteins using SNO-RAC (see Methods). 
Representative blot, n of 5 independent experiments. (C) Average percentage of proteins detected by 
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mass spectrometry as enriched in CysNO (≥ 2 fold vs control), unchanged (< 2, > 0.5; CysNO vs 
control), or enriched in controls (≤ 0.5 fold; CysNO vs control). Control groups constitute Cys only 
and CysNO without ascorbate. Data from 5 independent experiments are shown as mean +/- SEM. 
*p<0.05,**p<0.01 (Row means one-way ANOVA, Tukey). 
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Figure 2 
 
 
Fig. 2. S-nitrosylation of CREB and RBBP7 in cortical neurons. (A) E17 rat cortical neurons were 
cultured for 4 days and treated with CysNO (200 μM for 20 mins). S-nitrosylated proteins were 
isolated by SNORAC (n=2 independent experiments) or biotin switch (n=2 independent experiments). 
Non-contiguous lanes from the same experiment and blot are shown side by side. (B) Cortical neurons 
were exposed to KCL (50 mM for 20 mins) and S-nitrosylated proteins were isolated by SNORAC 
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(n=2 independent experiments) or biotin switch (n=1 independent experiment). Data combined for 
analysis. (C) Neurons were were treated with CysNO (200 μM for 20 mins) and S-nitrosylated 
proteins isolated by biotin switch (n=4 independent experiments). Non-contiguous lanes from the 
same experiment and blot are shown side by side. (D) Cortical neurons (4 days in vitro) were exposed 
to KCL and S-nitrosylated proteins isolated by biotin switch (n=2 independent experiments using 
KCL 30 mins, n=1 independent experiment for KCL 20 mins. Data combined for analysis). For both 
CREB and RBBP7, isolated proteins were separated by SDS-PAGE and western blot analysis was 
carried out using antibodies against CREB or RBBP7. Densitometry analysis on the western blots was 
performed using ImageJ. SNO-protein signals were first adjusted according to inputs. All data are 
shown as mean +/- SEM (Unpaired t-test, *P=<0.05, **P=<0.01, ***P=<0.0001). 
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Figure 3 
 
 
Fig. 3. Lysine motifs regulate S-nitrosylation (A) Cysteine-containing peptides associated with 
nuclear SNO-proteins were subjected to SNO-site analysis using Motif-X (see Methods) and the IPI 
rat proteome, as background. Graphical representation of the motifs; the size of each letters refers the 
probability of occurrence of that amino acid in cysteine containing peptides. Summary table displayed 
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for clarity. Full size letters (as for cysteine; C, lysine; K) indicate their recurrence in each motif. (B) 
Gene ontology (GO) analysis of proteins that contain either lysine motif 1, 2, 3 or 4 only around their 
identified S-nitrosylated cysteines. Analysis carried out using PANTHER Functional Classification 
for Biological Process, Version 13.1 released 2018-02-03, pantherdb.org. (C) SNO-motif mutational 
analysis of MBD3. Western blotting and densitometry analysis of HEK293T cells transfected with 
vectors expressing myc-tagged wild type MBD3 (WT), MBD3 cysteine-to-serine mutants (C215S and 
C266S), MBD3 lysine 264-to-alanine mutant (K264A) and cysteine and alanine combined mutant 
(C215S/K264A). 24h after transfection, cells were exposed to Cys or CysNO (200µM for 20 mins) 
and subjected to the biotin switch assay. n=4 independent experiments. Data are shown as mean +/- 
SEM (One-way ANOVA, compared to control column ‘WT + CysNO’, Fisher’s LSD, *p≤0.05). 
Non-contiguous lanes from the same experiment and blot are shown side by side, as indicated by the 
separation evident in the figure. (D) SNO-motif mutational analysis of HDAC2. Vectors expressing 
HA-tagged wild type HDAC2 (WT), HDAC2 cysteine-to-alanine nitrosomutant (C264A/C272A), 
HDAC2 lysine 280-to-alanine mutant (K280A) and cysteine and alanine combined mutant 
(C264A/K280A). 48h after transfection, cells were exposed to Cys or CysNO (200µM for 20 mins) 
and subjected to the biotin switch assay.  n=2 independent experiments. 
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Figure 4 
 
Fig. 4. SNO-site identification for CREB and RBBP7. (A) Domain structure of CREB. Q1= 
glutamine rich region 1, α= alpha domain, KID= kinase inducible domain, Q2= glutamine rich region 
2, bZIP= bZIP domain. CREB1 cysteines are annotated (C90, C300, C310, C337). Phosphorylated 
serines (S133, S142, S143) are shown along with their respective kinases (protein kinase A (PKA), 
protein kinase C (PKC) and Ca2+/calmodulin-dependent protein kinase II (CaMKII)) (B) Vectors 
expressing myc-tagged wild type CREB (WT) or CREB cysteine-to-serine mutants were transfected 
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into HEK293T cells, and after 48h, cell lysates were exposed to Cys or CysNO (500µM for 20 mins) 
and subjected to the biotin switch assay. n=3 independent experiments. (C) RBBP7 contains 7 WD-
repeat domains, composed of short motifs of approximately 40 amino acids and ending in a 
typrophan-aspartic acid dipeptide. (D) Vectors expressing myc-tagged wild type RBBP7 (WT) or 
RBBP7 cysteine 166 to serine mutant (C166S) were transfected into HEK293T cells. After 48h, cells 
were treated with Cys or CysNO (500µM for 20 mins) and lysates were subjected to the biotin switch 
assay. n=3 independent experiments. Isolated proteins and total inputs were separated by SDS-PAGE 
then immunoblotted using an antibody against myc. Densitometry analysis carried out using ImageJ. 
SNO-signals were normalised to total inputs and expressed as fold change relative to WT + CysNO. 
All data are shown as mean +/- SEM. One-way ANOVA, compared to ‘WT + CysNO’ column, 
Fisher’s LSD; *p≤0.05, **p<0.01. 
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Figure 5 
 
Fig. 5. S-nitrosylation of RBBP7 regulates dendritogenesis (A) S-nitrosylation of RBBP7 regulates 
the interaction with CHD4. E17 rat cortical neurons were cultured for 4 days, treated with 200μM 
CysNO for 20 minutes and subjected to co-immunoprecipitation using an antibody against CHD4. As 
a control, pooled samples (of Cys and CysNO) were subjected to immunoprecipition using an IgG 
antibody. Western blot analysis was carried out on eluates and inputs using indicated antibodies. 
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Densitometry analysis of co-immunoprecipitated RBBP7 shown in relation to co-immunoprecipitated 
CHD4 (n=4 independent experiments, **p<0.01, unpaired t-test). Densitometry was carried out by 
normalising RBBP7 pulldown signal to RBBP7 inputs, then dividing this value by the pulldown 
signal for CHD4. (B) S-nitrosylation of RBBP7 at cysteine 166 promotes the interaction with CHD4. 
HEK293T cells were transfected with vectors expressing Flag-mCHD4 and HA-RBBP7WT or HA-
RBBP7C166S, treated with 200μM CysNO for 20 mins and pulldown carried out on eluates using an 
antibody against HA. Western blot analysis was carried out on eluates and inputs using indicated 
antibodies. Densitometry analysis of FLAG-CHD4 displayed in relation to HA-RBBP7, normalised to 
FLAG-CHD4 inputs (n= 3 independent experiments, **p<0.01, unpaired t-test). Densitometry was 
carried out by normalising FLAG-CHD4 pulldown signal to FLAG-CHD4 inputs, then dividing this 
value by the pulldown signal for HA-RBBP7.  (C) S-nitrosylation of RBBP7 promotes 
dentritogenesis in cortical neurons. Control siRNA (CTL) or siRNAs targeting RBBP4 and RBBP7 
(siRBBP4/7) were transfected into E15 mouse cortical neurons alongside a GFP expression vector 
and EV, siRNA-resistant myc-RBBP7WT or myc-RBBP7C166S as shown. Neurons were maintained in 
control conditions (Ctl) or exposed to 50mM KCl (KCl) for 2 days and immunostained for GFP. 
Resulting images were analysed using FIJI Sholl plugin. Maximal projections show representative 
neurons for each condition. Scale bar: 100μm. Summary of Sholl data analysis for each condition is 
shown.  3 biological replicates were carried out in which 10 neurons were analysed per experiment 
(30 neurons in total). Shown are mean values for number of intersections (intersections) against 
distance from the soma (μm). Readings were taken every 10μm. *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001. Red stars indicate KCl value is significantly greater than Ctl, black stars indicate Ctl 
value is significantly greater than KCL. Row means two-way ANOVA with Sidak’s test for multiple 
comparisons. 
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Figure S1 
 
Fig. S1. SNORAC Screen Analysis. (A) Nuclear extracts from cortical neurons were treated with 
200μM Cys or CysNO for 20 minutes, followed by SNORAC and western blotting of isolates and 
inputs for HDAC2 (n=2 independent experiments). Sodium ascorbate is required for reduction of S-
nitrosothiols. (B) Nuclear and cytoplasmic extracts were treated with 200μM Cys or CysNO for 20 
minutes, followed by western blot for HDAC2 and Tubulin (representative blot of n=3 independent 
experiments). (C) Total number of proteins detected as enriched in CysNO (≥ 2 fold) groups in each 
experiment. Proteins were compiled from both ‘CysNO vs Cys’ and ‘CysNO vs CysNO w/o 
ascorbate’ for each experiment. (D) Comparison of the number of proteins detected as ≥ 2 fold 
enriched in CysNO versus control groups, in at least 1 experiment. (E) Relative proportion of proteins 
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detected as enriched either ≥ 2 fold in CysNO groups (green), unchanged (grey) or enriched ≥ 2 fold 
in controls (red). CysNO concentration in experiments 1 and 2 is 1mM CysNO and 200μM in 
experiments 3-5.  
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Figure S2 
 
 
 
Fig. S2. PANTHER Gene Ontology Overrepresentation Analysis. Overepresentation analysis was 
carried out using S-nitrosylated hits (Table S2) as the assayed dataset and our nuclear protein dataset 
(Table S7) as background. P>0.05 (-log10(P) of 1.3 and above) was considered as statistically 
significant; all terms displayed here reach this threshold, indicated by dashed green line. Bonferroni 
correction for multiple testing was carried out. Displayed are the parent terms only.  Shown are 
overrepresented terms for Pathways (A), Molecular Function (B), Biological Process (C) and Protein 
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Class (D). Analysis carried out using PANTHER Overrepresentation Test (release 20170413); 
PANTHER version 12 Released 2017-07-10, pantherdb.org. 
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Figure S3 
 
 
Fig. S3. Gene Ontology Standard Classifications. GO analysis of S-nitrosylated hits listed in Table 
S2. (A) Protein Class (PANTHER, version 11.1); 530 annotations were assigned for S-nitrosylated 
proteins identified in nuclear extracts, 426 annotations for cytoplasmic S-nitrosylated proteins. The 
three most commonly annotated terms for each dataset are highlighted in yellow. (B) Overlap 
between nuclear and cytoplasmic SNO-P datasets. (C) Exclusive annotations for cellular component 
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(Uniprot terms as assigned by Proteome Discover software). The number of times a particular term is 
assigned unambiguously, i.e. when no other term is present are shown. (D) Total annotations for 
cellular component (Uniprot terms, Proteome Discover). The percentage of annotated hits that were 
assigned each particular term. This includes the majority of cases in which multiple terms were 
assigned. 
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Figure S4 
 
Fig. S4. GSNO-dependent S-nitrosylation of HDAC2, RBBP7, RBBP4 and MBD3. Neurons 
were treated with Cys, CysNO, GSH or GSNO (200 μM for 20 mins) and S-nitrosylated proteins 
isolated by biotin switch (representative blots, n=2 independent experiments). Western blot was 
carried out on biotin switch samples and inputs using the displayed antibodies. 
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Figure S5 
 
 
Fig. S5. S-nitrosylation of CHD3, CHD4 and CHD5. Vectors expressing flag-tagged hCHD3, 
mCHD4 and hCHD4 were transfected in HEK293T cells. After 48h, cell lysates were treated with 
Cys or CysNO (200µM for 20 mins) and subjected to the biotin switch assay using NEM (n=3 
independent experiments) or MMTS (n=3 independent experiments) blocking conditions. Data was 
combined for densitometry analysis. Isolated proteins and total inputs were separated by SDS-PAGE 
followed by immunoblotting using a flag antibody. Densitometry analysis was carried out using 
ImageJ. SNO-signals were normalised to total inputs and expressed as fold change relative to CysNO. 
All data are shown as mean +/- SEM (n= 6), **p<0.01, ***p<0.001, ****p<0.0001 unpaired t-test. 
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Figure S6 
 
 
 
Fig. S6. CREB phosphorylation at serine 133 is unaffected in C300/310/337S mutant. HEK293T 
cells were transfected with empty vector (EV), myc-tagged wildtype (WT) or C300/310/337S mutant 
(triple mutant; TM) CREB and after 48h, were treated with forskolin (50µM for 10 or 60 minutes). 
Proteins from cell lysates were separated by SDS-PAGE followed by western blotting using an 
antibody against CREB phosphoserine 133 (pS133). Expression levels of transfected plasmids were 
assessed with myc antibody and endogenous CREB levels were assessed using a CREB antibody. 
Densitometry analysis on western blots was carried out using ImageJ; pS133 signals were normalised 
to mycCREB, and values expressed as fold change of the pS133 signal in WT mycCREB upon 10 
mins FSK treatment. All data are shown as mean +/- SEM. One way ANOVA, Fisher’s LSD, 
*p<0.05, **p<0.01, ns= not significant, n=3 independent experiments. 
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Figure S7 
 
 
Fig. S7. RBBP7/4 sequence conservation and SNO-site analysis for RBBP4 and MBD3. (A) 
Sequence homology between rat, human and mouse RBBP7 and rat RBBP4. Sequence alignment 
carried out using Clustal Omega (Embl-Ebi). (B) Vectors expressing myc-tagged wild type rtRBBP4 
(WT) or RBBP4 cysteine 167 to serine mutant (C167S) were transfected in HEK29sT2 cells. 48h 
after transfection cells were treated with Cys or CysNO and lysates subjected to biotin switch assay. 
Isolated proteins and total inputs were separated by SDS-PAGE followed by immunoblotting using a 
myc antibody. Densitometry analysis was carried out using ImageJ. SNO-signals were first 
normalised to total inputs and expressed as fold change relative to WT +CysNO. All data are shown 
as mean +/- SEM. *p<0.05, **p<0.01, One-way ANOVA compared to WT +CysNO column, Fisher’s 
LSD. (B) n=6 independent experiments. 
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Figure S8 
 
 
 
Fig. S8. RBBP7 knockdown and dentritogenesis analysis. (A). RBBP7 knockdown in N2a cells. 
N2a cells were transfected with a GFP expression vector together with 200nM of either control 
siRNA (CTL) or targeting RBBP7 (siRBBP7). Cells were harvested 48h after transfection. Western 
blot analysis of RBBP7, tubulin, HSP90 and GFP levels. Densitometry analysis of western blots was 
carried out using ImageJ. RBBP7 signal normalised to tubulin and GFP. **p<0.01 unpaired t-test. 
n=3 independent experiments. (B) RBBP7 knockdown on activity-induced dentritogenesis in cortical 
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neurons. Control siRNA (CTL) or siRNA against RBBP7 (siRBBP7) was transfected into E15 mouse 
cortical neurons alongside a GFP expression vector and mycEV. Neurons were maintained in normal 
media (Ctl) or in the presence of 50mM KCl (KCl) for 2 days then immunostained using an anti-GFP 
antibody. Images were analysed using Fiji Sholl plugin. Maximal projections show representative 
neurons for each condition. Scale bar 100μM. Summary of Sholl data for each condition is shown. 3 
biological replicates were carried out and 10 neurons analysed per experiment (30 neurons in total). 
Shown are the mean values for number of intersections (y axis) against distance from soma (x axis; 
μm). Readings were taken every 10μm. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 two-way 
ANOVA with Sidak’s test for multiple comparisons. Red stars indicate KCl value is significantly 
greater than Ctl. (C) Confirmation of RBBP4/7 double knockdown. 2a cells were co-transfected with 
GFP expression vector and 400nM total RNA of either control siRNA (CTL) or siRNA’s against 
RBBP4 and RBBP7 in a 1:1 ratio (siRBBP4/7). Cells were harvested 48hrs post transfection and 
analysed by Western blot. Western blot of RBBP7, RBBP4 and HSP90 is shown. Densitometry 
analysis of western blots carried out using ImageJ. RBBP7 and RBBP4 levels were normalised to 
HSP90. All data are shown as mean +/- SEM. **p<0.01, unpaired t-test (n=3 independent 
experiments). (D) Expression of siRNA-resistant myc-RBBP7WT RBBP7C166S. N2a cells were 
transfected with either myc-EV, siRNA-resistant myc-RBBP7WT or RBBP7C166S and siRNA CTL or 
the double knockdown siRBBP4/7. 48hrs after transfection cells were harvested and levels of RBBP7, 
RBBP4, HSP90 analysed by Western blot. RBBP7 levels in RBBP7WT and RBBP7C166S conditions 
were quantified by densitometry, using HSP90 as a loading control. ns= not significant (unpaired t-
test, n=3 independent experiments). Data are shown as mean +/- SEM.  
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